Merck sales soar but 3Q profit dips on higher spending

Big jumps in sales of Merck's top two blockbuster drugs drove revenue up 15 percent, but higher spending across the board pushed profits down 3 percent in the third quarter. Merck still easily beat Wall Street forecasts and boosted its forecast for the year. The quarter were dominated again by advanced cancer drug Keytruda, with sales ...

Enter your user name and password in the fields above to gain access to the subscriber content on this site. Need a subscription? Click here.
Your subscription includes one set of login credentials for your exclusive use. Security features have been integrated on this site: If someone signs in with your credentials while you are logged in, the site will automatically close your ongoing login and you will lose access at that time.
If you feel your login credentials are being used by a second party, contact customer service at 877-615-9536 for assistance in changing your password.

Already a paid subscriber but not registered for online access yet? For instructions on how to get premium web access, click here.

Forgot your password?

MLM Counties News. Notices. Need-to-know Information.

Merck sales soar but 3Q profit dips on higher spending

Leave a Reply